Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

Comment by Jennifer2020on Dec 26, 2020 4:24pm
197 Views
Post# 32184148

RE:What the hell

RE:What the hellInsiders hold about 80% of this company and by lack of ANY meaningful investor relations are slowly allowing their friends and family to buy the other 20% at bargain prices.  When all is ready, they will stop giving all the value away to the Swiss AG interests and let the price finally run.  Just my not so humble opinions. 

   The $723,000 research agreement with Ritec AG is a perfect example.  It would have been cause for a SP strengthing news release WITH ANY other company.  Instead we only know of it because some of us read the entire SEDAR MD&A 
  
  It constitutes more revenue than MIR had in 2019, just like the $850,000 down payment on the 3.5 million dollar initial order from Webb Diagnostics in the summer was.

  This agreement might finally be the signal that said value has finally started to shift to MIR

jmo's dyodd


<< Previous
Bullboard Posts
Next >>